Commentator views former Ørsted CEO as potential Novo Nordisk chairman

For life science companies, it's no longer enough to have experts from own industry in the board room, according to business commentator Jens Christian Hansen. He sees many advantages to Novo Nordisk's interest in including former Ørsted CEO Henrik Poulsen in the company board.

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs